(Date:11/25/2009)...Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopl...ropractorcanalsogivepatientsthehelptheyneed.TMJsta...jaw(mandible)contacts/connectswithyourskull(tempor...TMJdysfunctionarepainwithchewing,clickingorpopping...functionincluding:headaches,fatigue,sleepdisturban...
(Date:11/25/2009)...ACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswi...nthegreaterLongBeachareathankstoFaithInAction/Volu...atHome(IAH),adivisionofSCANHealthPlan.Formorethan1...nteerstodeliverwarmThanksgivingmealstoseniorsinnee...Angelesandsurroundingcities. ,, "Ourwarmholiday...
(Date:11/25/2009)...rvivors of testicular cancer who were treated with... effects, including neurological side effects and ...ted with chemotherapy, according to a new study pu...National Cancer Institute . , Marianne Brydy, M....rsity Hospital, in Bergen, Norway, and colleagues ...
(Date:11/25/2009)...eady used to fight rheumatoid arthritis, could hel... , WEDNESDAY, Nov. 25 (HealthDay News) -- A drug... rheumatoid arthritis now also shows some promise ...abetes. , The drug, rituximab (Rituxan), helped..., even though the disease had destroyed some of th...
(Date:11/25/2009)...K,Nov.25/PRNewswire/-- MISSIONSkincare ®ispro...St.Jude.AspartofGNC,sannualSt.Jude ThanksandGiving...ncare,s new SUPER-C(TM)LipBalm willbedonatedtoSt...omakea$1,$5or$10donationatcheckoutatoneoftheir5,00...an$1millionforSt.Judeduringtheir2009 ThanksandGivi...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2...RG, S.C., Feb. 10 Zeus, Inc. is pleased to introd...live and accessible via http://www.zeusinc.com . ... site is a user-friendly resource for comprehensiv...t of information into four categories listed on th...
..., Ill., Feb. 10 A prestigious panel of pain-manag...ty (APS) www.ampainsoc.org and the American Acad...t comprehensive clinical practice guideline to ass...rent issue of The Journal of Pain , www.jpain.or...
... Cambridge Healthtech Media Group,...ounced the launch of a new website devoted to excl... --www.ecliniqua.com. , N...website devoted to exclusive coverage of the clini...
...ts at the Institute for Myeloma and Bone Cancer Re...ould explain how blood vessels form within tumors....vered a new way that cancers orchestrate the produ...by tumor cells in multiple myeloma, a common form ...
...INGTON, Del., Feb. 10 Four western New York hospi...ing evidence-based therapy and,better communicatio... patient,deaths by 19 percent for up to one year a...Mortality in Patients,with Acute Coronary Syndrome...
...ARD, Calif., Feb. 10 Arete Therapeutics Inc. toda... trial for AR9281, an orally-,administered soluble...d for,the treatment of type 2 diabetes. S-EH is an... "Our AR9281 Phase II clinical trial program break...
Other Medicine News:Health News:New Guidelines for Prescribing Opioid Pain Drugs Published 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3Health News:Researchers Identify Novel Mechanism That Make Cancer Tumors Grow 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 2Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 3Health News:Emergency Treatment Strategies, Better Communication Among Health Care Workers Reduce Heart Attack Patient Deaths by 19 Percent, Says AHJ Published Study 4Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 2Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 3